Keywords: merck, co/lundbeck, delay, gabodaxol, filing, drug, major

Merck & Co/Lundbeck delay gabodaxol filing

Article | 23 October 2006

Print This

US drug major Merck & Co and Denmark's H Lundbeck AS have delayed their submission of a New Drug Application for ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in